Delivery Order SPE2DB22D2206-SPE2DB23FDZ20

Award Date 11/4/22
Potential Completion Date 11/29/22
Potential Value $78K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $78,114.24 firm fixed-price delivery order is for the supply of 4,558 units of KEYTRUDA 100 mg/4 ml vials. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $78,114.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KEYTRUDA 100 MG/4 ML VIAL 4ML, a medical product, and is a Firm Fixed Price Delivery Order contract with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $78,114.24 Firm Fixed Price Delivery Order is for the provision of KEYTRUDA 100 MG/4 ML VIAL 4ML, a critical medical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $76,403.88, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of KEYTRUDA 100 MG/4 ML VIAL 4ML, a specialty medication, to support military healthcare programs. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support...
This federal contract award is for the delivery of Keytruda 100 mg/4 ml vials to the Defense Logistics Agency (DLA). The $127,339.80 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 31, 2021. The contract has an ultimate completion date of September 22, 2021 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This federal contract award is for pharmaceutical products and medical supplies provided by AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $78,114.24, is for the delivery of Keytruda 100 mg/4 ml vials. The contract is a delivery order issued under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $76,403.88, is for the delivery of Keytruda 100 mg/4 ml vials to support military and government medical programs. The award was made on a firm fixed-price basis without any set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $78,114.24, is for the delivery of Keytruda 100 mg/4 ml vials. This is a firm-fixed-price delivery order contract with a completion date of May 18, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a for-profit organization registered in the System for Award Management...
This federal contract award, valued at $78,114.24, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of KEYTRUDA 100 mg/4 ml vials to support military treatment programs and facilities. The potential value of the contract is $152,807.76, and the completion date is October 8, 2021. The contract was not...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB23FDZ20
    Delivery Order

This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $78,114.24, is for the delivery of KEYTRUDA 100 MG/4 ML VIAL 4ML, a critical pharmaceutical product.

The award is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract does not have a set-aside designation, indicating open competition. As a major supplier of medical products to federal government agencies, particularly within military and veterans' healthcare systems, AmerisourceBergen demonstrates a breadth of pharmaceutical and medical supply procurement across multiple federal contracts.

Generated 4/1/25, 7:35 PM